Most patients still need to be managed by oral medications to treat diabetes and not injections, at least in the early stages ...
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
Clinical trials show that around one in ten people are ‘non-responders’. Outside of trials, that figure might be much higher.
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
But their weight-loss properties grabbed the attention of the public and people without diabetes started seeking these ...
Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...
The dosage of semaglutide in Wegovy is higher than in Ozempic, which is why Wegovy tends to lead to greater weight loss results​​. For those focused purely on weight loss, Wegovy may offer more ...
There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...
The diabetes drug, Ozempic, has been in the headlines, causing quite a stir. Senior writer for Drugwatch.com, Terry Turner, ...
A row is brewing between the White House and Robert F Kennedy Jr after the Biden administration proposed making millions of ...